detrusan┬« technology is CE marked and it has obtained FDA clearance and
is now available worldwide for the treatment of Urinary Incontinence.
EMED is continuing to improve detrusan® technology including optimization of stimulation parameters and its applications. EMED works under strict quality protocols and research institution review boards to ensure regulatory compliance of its present and future devices.
EMED Technologies is ISO 13485 certified. Our registrar is LNE / GMED.